机构:[1]Department of Ultrasound, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.[2]Department of Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.[3]Department of Radiology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.四川省人民医院四川省肿瘤医院[4]Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
National Natural Science
Foundation of China [82120108015, 82071874 and 81971586]; the
Sichuan Science and Technology Program [2020YFS0050,
2020YJ0029, 2020YFS0131, 2019YFS0430 and 19ZDYF] and the
Fundamental Research Funds for the Central Universities
[SCU2020D4132].
第一作者机构:[1]Department of Ultrasound, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Ye Lu,Wang Dan-Qing,Yang Meng-Xi,et al.Chemotherapy effect on myocardial fibrosis markers in patients with gynecologic cancer and low cardiovascular risk[J].FRONTIERS IN ONCOLOGY.2023,13:doi:10.3389/fonc.2023.1173838.
APA:
Ye Lu,Wang Dan-Qing,Yang Meng-Xi,Li Qing-Li,Luo Hong...&Guo Ying-Kun.(2023).Chemotherapy effect on myocardial fibrosis markers in patients with gynecologic cancer and low cardiovascular risk.FRONTIERS IN ONCOLOGY,13,
MLA:
Ye Lu,et al."Chemotherapy effect on myocardial fibrosis markers in patients with gynecologic cancer and low cardiovascular risk".FRONTIERS IN ONCOLOGY 13.(2023)